Table 1 Comparative analysis of mouse and human Clec9a: gene structure, protein features, and immunological roles

From: Exploring Clec9a in dendritic cell-based tumor immunotherapy for molecular insights and therapeutic potentials

Feature

Mouse

Human

Gene structure50,51

7 exons spanning 13.4 kb.

6 exons spanning 12.9 kb.

Protein structure50,51

Type II transmembrane protein, 264 amino acids, CTLD, transmembrane region, cytoplasmic tail.

Type II transmembrane protein, 241 amino acids, CTLD, transmembrane region, cytoplasmic tail.

Key role in immune system66,109

Antigen processing in cDC1, presenting antigens from dead cells to CD8+ T cells.

Antigen processing in cDC1, presenting antigens from dead cells to CD8+ T cells.

Molecular mass49

Predicted ~30 kDa, dimer formation

Predicted ~30 kDa, dimer formation

Structural identity49

53% identity with human Clec9a.

Shares most structural features with mouse Clec9a.

Special characteristics50

Additional N-glycosylation site, unique cysteine in stalk region, lacks Ca2+-coordinating residues in CTLD.

Lacks Ca2+-coordinating residues in CTLD, multiple sites for glycosaminoglycans.